Although bioinformatic approaches using the TCGA database suggest a low mutation frequency of clock genes [196], dysregulated clock gene expression in human cancer such as epigenetic silencing by promoter methylation, dysregulation at the transcriptional or post-transcriptional level, and gene polymorphism has been observed [197,198,199]. This evidence concerns the gene CLOCK and cancer.